PubMed:8622883
Annnotations
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 1346-1349 | gene:1029 | denotes | p16 |
| T1 | 1298-1306 | disease:C0023418 | denotes | leukemia |
| R1 | T0 | T1 | associated_with | p16,leukemia |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 12-15 | protein | denotes | p16 |
| T2 | 23-53 | protein | denotes | E2F-dependent thymidine kinase |
| T3 | 97-123 | DNA | denotes | MTS1 tumor suppressor gene |
| T4 | 127-142 | DNA | denotes | chromosome 9p21 |
| T5 | 158-161 | protein | denotes | p16 |
| T6 | 180-211 | protein | denotes | cyclin-dependent-kinase-4 and 6 |
| T7 | 271-293 | protein | denotes | retinoblastoma protein |
| T8 | 297-329 | protein | denotes | cyclin-dependent kinases 4 and 6 |
| T9 | 364-384 | protein | denotes | transcription factor |
| T10 | 385-388 | protein | denotes | E2F |
| T11 | 436-459 | DNA | denotes | S phase regulated genes |
| T12 | 469-485 | protein | denotes | thymidine kinase |
| T13 | 506-509 | protein | denotes | p16 |
| T14 | 591-612 | DNA | denotes | tumor suppressor gene |
| T15 | 628-631 | protein | denotes | E2F |
| T16 | 688-704 | protein | denotes | thymidine kinase |
| T17 | 708-762 | cell_line | denotes | phytohemagglutinin-stimulated normal human lymphocytes |
| T18 | 774-832 | cell_line | denotes | p16-negative human acute lymphoblastic leukemia cell lines |
| T19 | 834-840 | cell_line | denotes | MOLT-4 |
| T20 | 845-848 | cell_line | denotes | CEM |
| T21 | 862-880 | cell_type | denotes | normal lymphocytes |
| T22 | 882-902 | cell_line | denotes | MOLT-4 and CEM cells |
| T23 | 949-965 | protein | denotes | thymidine kinase |
| T24 | 1012-1018 | protein | denotes | enzyme |
| T25 | 1031-1052 | RNA | denotes | thymidine kinase mRNA |
| T26 | 1089-1092 | protein | denotes | p16 |
| T27 | 1187-1207 | cell_line | denotes | MOLT-4 and CEM cells |
| T28 | 1249-1271 | protein | denotes | retinoblastoma protein |
| T29 | 1298-1317 | cell_line | denotes | leukemia cell lines |
| T30 | 1346-1349 | protein | denotes | p16 |
| T31 | 1389-1405 | protein | denotes | thymidine kinase |
| T32 | 1468-1490 | protein | denotes | retinoblastoma protein |
| T33 | 1512-1515 | protein | denotes | E2F |
| T34 | 1542-1567 | DNA | denotes | thymidine kinase promoter |
| T35 | 1597-1600 | protein | denotes | p16 |
| T36 | 1651-1657 | protein | denotes | enzyme |
| T37 | 1676-1679 | protein | denotes | E2F |
| T38 | 1705-1727 | protein | denotes | retinoblastoma protein |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 8622883-1#114#139#gene1019 | 180-205 | gene1019 | denotes | cyclin-dependent-kinase-4 |
| 8622883-1#150#163#diseaseC0596263 | 216-229 | diseaseC0596263 | denotes | tumorigenesis |
| 8622883-7#73#76#gene1029 | 1346-1349 | gene1029 | denotes | p16 |
| 8622883-7#25#33#diseaseC0023418 | 1298-1306 | diseaseC0023418 | denotes | leukemia |
| 114#139#gene1019150#163#diseaseC0596263 | 8622883-1#114#139#gene1019 | 8622883-1#150#163#diseaseC0596263 | associated_with | cyclin-dependent-kinase-4,tumorigenesis |
| 73#76#gene102925#33#diseaseC0023418 | 8622883-7#73#76#gene1029 | 8622883-7#25#33#diseaseC0023418 | associated_with | p16,leukemia |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-65 | Sentence | denotes | The role of p16 in the E2F-dependent thymidine kinase regulation. |
| S2 | 66-247 | Sentence | denotes | The role of alterations of the MTS1 tumor suppressor gene on chromosome 9p21, which encodes p16, the inhibitor of cyclin-dependent-kinase-4 and 6, in tumorigenesis is not yet clear. |
| S3 | 248-486 | Sentence | denotes | Phosphorylation of the retinoblastoma protein by cyclin-dependent kinases 4 and 6 prevents its interaction with the transcription factor E2F, which subsequently promotes the expression of S phase regulated genes, such as thymidine kinase. |
| S4 | 487-653 | Sentence | denotes | Although a role of p16 in this regulation has been presumed, there is no proof so far that loss of this tumor suppressor gene really affects E2F-mediated regulations. |
| S5 | 654-849 | Sentence | denotes | We investigated the regulation of thymidine kinase in phytohemagglutinin-stimulated normal human lymphocytes and in the p16-negative human acute lymphoblastic leukemia cell lines, MOLT-4 and CEM. |
| S6 | 850-1064 | Sentence | denotes | Compared to normal lymphocytes, MOLT-4 and CEM cells exhibited an altered cell cycle regulation of thymidine kinase, a much higher intracellular activity of this enzyme, and higher thymidine kinase mRNA expression. |
| S7 | 1065-1272 | Sentence | denotes | Transient expression of p16 in normal human lymphocytes caused arrest in G1, but was without effect on the cell growth of MOLT-4 and CEM cells, although all of them express functional retinoblastoma protein. |
| S8 | 1273-1568 | Sentence | denotes | Nevertheless, in the two leukemia cell lines transient overexpression of p16 reestablished the normal regulation of thymidine kinase, paralleled by an increase of the underphosphorylated form of retinoblastoma protein and decrease of free E2F bound to its motif in the thymidine kinase promoter. |
| S9 | 1569-1728 | Sentence | denotes | We demonstrate that loss of p16 causes upregulation of this DNA precursor pathway enzyme via activation of E2F by a mechanism involving retinoblastoma protein. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 12-15 | NP | denotes | p16 |
| C2 | 23-27 | NP | denotes | E2F- |
| C3 | 93-123 | NP | denotes | the MTS1 tumor suppressor gene |
| C4 | 127-142 | NP | denotes | chromosome 9p21 |
| C5 | 144-149 | NP | denotes | which |
| C6 | 158-161 | NP | denotes | p16 |
| C7 | 163-211 | NP | denotes | the inhibitor of cyclin-dependent-kinase-4 and 6 |
| C8 | 267-293 | NP | denotes | the retinoblastoma protein |
| C9 | 339-342 | NP | denotes | its |
| C10 | 360-388 | NP | denotes | the transcription factor E2F |
| C11 | 390-395 | NP | denotes | which |
| C12 | 469-485 | NP | denotes | thymidine kinase |
| C13 | 506-509 | NP | denotes | p16 |
| C14 | 560-565 | NP | denotes | proof |
| C15 | 573-577 | NP | denotes | that |
| C17 | 586-612 | NP | denotes | this tumor suppressor gene |
| C16 | 578-612 | NP | denotes | loss of this tumor suppressor gene |
| C18 | 628-632 | NP | denotes | E2F- |
| C19 | 688-704 | NP | denotes | thymidine kinase |
| C21 | 774-778 | NP | denotes | p16- |
| C20 | 770-832 | NP | denotes | the p16-negative human acute lymphoblastic leukemia cell lines |
| C22 | 834-848 | NP | denotes | MOLT-4 and CEM |
| C23 | 862-880 | NP | denotes | normal lymphocytes |
| C24 | 882-902 | NP | denotes | MOLT-4 and CEM cells |
| C25 | 949-965 | NP | denotes | thymidine kinase |
| C26 | 1007-1018 | NP | denotes | this enzyme |
| C27 | 1089-1092 | NP | denotes | p16 |
| C28 | 1096-1120 | NP | denotes | normal human lymphocytes |
| C29 | 1187-1207 | NP | denotes | MOLT-4 and CEM cells |
| C31 | 1225-1229 | NP | denotes | them |
| C30 | 1218-1229 | NP | denotes | all of them |
| C32 | 1346-1349 | NP | denotes | p16 |
| C33 | 1389-1405 | NP | denotes | thymidine kinase |
| C34 | 1468-1490 | NP | denotes | retinoblastoma protein |
| C35 | 1525-1528 | NP | denotes | its |
| C37 | 1597-1600 | NP | denotes | p16 |
| C36 | 1589-1600 | NP | denotes | loss of p16 |
| C38 | 1624-1657 | NP | denotes | this DNA precursor pathway enzyme |
| C39 | 1676-1679 | NP | denotes | E2F |
| C40 | 1705-1727 | NP | denotes | retinoblastoma protein |
| R1 | C5 | C4 | coref-relat | which,chromosome 9p21 |
| R2 | C6 | C1 | coref-ident | p16,p16 |
| R3 | C7 | C6 | coref-appos | the inhibitor of cyclin-dependent-kinase-4 and 6,p16 |
| R4 | C9 | C8 | coref-pron | its,the retinoblastoma protein |
| R5 | C10 | C2 | coref-ident | the transcription factor E2F,E2F- |
| R6 | C11 | C10 | coref-relat | which,the transcription factor E2F |
| R7 | C13 | C6 | coref-ident | p16,p16 |
| R8 | C15 | C14 | coref-relat | that,proof |
| R9 | C17 | C3 | coref-ident | this tumor suppressor gene,the MTS1 tumor suppressor gene |
| R10 | C18 | C10 | coref-ident | E2F-,the transcription factor E2F |
| R11 | C19 | C12 | coref-ident | thymidine kinase,thymidine kinase |
| R12 | C21 | C13 | coref-ident | p16-,p16 |
| R13 | C22 | C20 | coref-appos | MOLT-4 and CEM,the p16-negative human acute lymphoblastic leukemia cell lines |
| R14 | C24 | C22 | coref-ident | MOLT-4 and CEM cells,MOLT-4 and CEM |
| R15 | C25 | C19 | coref-ident | thymidine kinase,thymidine kinase |
| R16 | C26 | C25 | coref-ident | this enzyme,thymidine kinase |
| R17 | C27 | C21 | coref-ident | p16,p16- |
| R18 | C28 | C23 | coref-ident | normal human lymphocytes,normal lymphocytes |
| R19 | C31 | C29 | coref-pron | them,MOLT-4 and CEM cells |
| R20 | C30 | C29 | coref-ident | all of them,MOLT-4 and CEM cells |
| R21 | C32 | C27 | coref-ident | p16,p16 |
| R22 | C33 | C25 | coref-ident | thymidine kinase,thymidine kinase |
| R23 | C35 | C34 | coref-pron | its,retinoblastoma protein |
| R24 | C37 | C32 | coref-ident | p16,p16 |
| R25 | C36 | C16 | coref-ident | loss of p16,loss of this tumor suppressor gene |
| R26 | C38 | C26 | coref-ident | this DNA precursor pathway enzyme,this enzyme |
| R27 | C39 | C18 | coref-ident | E2F,E2F- |
| R28 | C40 | C34 | coref-ident | retinoblastoma protein,retinoblastoma protein |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 12-15 | protein_molecule | denotes | p16 |
| T2 | 23-53 | protein_molecule | denotes | E2F-dependent thymidine kinase |
| T3 | 97-101 | DNA_domain_or_region | denotes | MTS1 |
| T4 | 127-142 | DNA_molecule | denotes | chromosome 9p21 |
| T5 | 158-161 | protein_molecule | denotes | p16 |
| T6 | 216-229 | other_name | denotes | tumorigenesis |
| T7 | 271-293 | protein_family_or_group | denotes | retinoblastoma protein |
| T8 | 364-384 | protein_family_or_group | denotes | transcription factor |
| T9 | 385-388 | protein_molecule | denotes | E2F |
| T10 | 436-443 | other_name | denotes | S phase |
| T11 | 469-485 | protein_family_or_group | denotes | thymidine kinase |
| T12 | 506-509 | protein_molecule | denotes | p16 |
| T13 | 591-612 | DNA_domain_or_region | denotes | tumor suppressor gene |
| T14 | 628-631 | protein_molecule | denotes | E2F |
| T15 | 688-704 | protein_family_or_group | denotes | thymidine kinase |
| T16 | 708-726 | protein_molecule | denotes | phytohemagglutinin |
| T17 | 774-777 | protein_molecule | denotes | p16 |
| T18 | 834-840 | cell_line | denotes | MOLT-4 |
| T19 | 845-848 | cell_line | denotes | CEM |
| T20 | 862-880 | cell_type | denotes | normal lymphocytes |
| T21 | 924-945 | other_name | denotes | cell cycle regulation |
| T22 | 949-965 | protein_family_or_group | denotes | thymidine kinase |
| T23 | 1012-1018 | protein_family_or_group | denotes | enzyme |
| T24 | 1031-1047 | protein_family_or_group | denotes | thymidine kinase |
| T25 | 1089-1092 | protein_molecule | denotes | p16 |
| T26 | 1249-1271 | protein_family_or_group | denotes | retinoblastoma protein |
| T27 | 1298-1317 | cell_line | denotes | leukemia cell lines |
| T28 | 1346-1349 | protein_molecule | denotes | p16 |
| T29 | 1389-1405 | protein_family_or_group | denotes | thymidine kinase |
| T30 | 1468-1490 | protein_family_or_group | denotes | retinoblastoma protein |
| T31 | 1512-1515 | protein_molecule | denotes | E2F |
| T32 | 1542-1558 | protein_family_or_group | denotes | thymidine kinase |
| T33 | 1597-1600 | protein_molecule | denotes | p16 |
| T34 | 1629-1650 | other_name | denotes | DNA precursor pathway |
| T35 | 1651-1657 | protein_family_or_group | denotes | enzyme |
| T36 | 1676-1679 | protein_molecule | denotes | E2F |
| T37 | 1705-1727 | protein_family_or_group | denotes | retinoblastoma protein |